DOI: 10.1016/j.diagmicrobio.2005.10.002. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002

Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004

10.1016/j.diagmicrobio.2005.10.002

Crossref journal-article

Elsevier BV

Diagnostic Microbiology and Infectious Disease (78)

Bibliography

Unal, S., & Garcia-Rodriguez, J. A. (2005). Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002â2004. Diagnostic Microbiology and Infectious Disease, 53(4), 265â271.

Authors 2

Serhat Unal (first)
Jose Angel Garcia-Rodriguez (additional)

References 49 Referenced 55

10.1093/jac/45.5.695 / J. Antimicrob. Chemother. / Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in Turkey by Aksaray (2000)
10.2165/00003495-199958010-00005 / Drugs / Current guidelines for the treatment and prevention of nosocomial infections by Bergogne-Berezin (1999)
10.1007/BF03160479 / Curr. Infect. Dis. Rep. / The increasing role of Acinetobacter species as nosocomial pathogens by Bergogne-Berezin (2001)
10.1007/s10096-005-1294-x / Eur. J. Clin. Microbiol. Infect. Dis. / Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: Molecular epidemiology and in vitro activity of polymyxin B by Bratu (2005)
10.1097/01.qco.0000136927.29802.68 / Curr. Opin. Infect. Dis. / Epidemiology and control of antibiotic resistance in the intensive care unit by Carlet (2004)
10.1016/j.ijantimicag.2004.03.016 / Int. J. Antimicrob. Agents / Antibiotic policies in Central Eastern Europe by Cizman (2004)
{'key': '10.1016/j.diagmicrobio.2005.10.002_bib7', 'series-title': 'Performance standards for antimicrobial susceptibility testing', 'author': 'Clinical and Laboratory Standards Institute', 'year': '2005'} / Performance standards for antimicrobial susceptibility testing by Clinical and Laboratory Standards Institute (2005)
10.1046/j.1469-0691.2000.00062.x / Clin. Microbiol. Infect. / Meropenem: Clinical response in relation to in vitro susceptibility by Drusano (2000)
10.1046/j.1469-0691.2002.00436.x / Clin. Microbiol. Infect. / Antibiotic resistance—from pathogen to disease surveillance by Finch (2002)
10.1007/s100960050497 / Eur. J. Clin. Microbiol. Infect. Dis. / Antimicrobial resistance in European isolates of Pseudomonas aeruginosa by Fluit (2000)
10.1086/320183 / Clin. Infect. Dis. / Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997–1999) by Gales (2001)
10.1179/joc.2002.14.1.25 / J. Chemother. / Antimicrobial resistance in gram-negative isolates from European intensive care units: Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme by Garcia-Rodriguez (2002)
10.1016/S0732-8893(01)00320-0 / Diagn. Microbiol. Infect. Dis. / MYSTIC Program: Summary of European data from 1997 to 2000 by Goossens (2001)
10.1001/jama.281.1.67 / JAMA / Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups by Hanberger (1999)
10.1093/jac/47.6.789 / J. Antimicrob. Chemother. / Antimicrobial susceptibility of Pseudomonas aeruginosa: Results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test by Henwood (2001)
10.1378/chest.119.2_suppl.397S / Chest / Resistance patterns among nosocomial pathogens: Trends over the past few years by Jones (2001)
10.1016/j.diagmicrobio.2004.03.016 / Diagn. Microbiol. Infect. Dis. / Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003) by Jones (2004)
10.1016/S0732-8893(02)00390-5 / Diagn. Microbiol. Infect. Dis. / Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: Summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000) by Jones (2002)
10.1016/S0732-8893(01)00318-2 / Diagn. Microbiol. Infect. Dis. / Determining the value of antimicrobial surveillance programs by Jones (2001)
10.1016/S0732-8893(98)00037-6 / Diagn. Microbiol. Infect. Dis. / Bacterial resistance: A worldwide problem by Jones (1998)
10.1016/j.diagmicrobio.2004.03.003 / Diagn. Microbiol. Infect. Dis. / Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa from the MYSTIC surveillance program: The OPTAMA Program, South America 2002 by Kiffer (2004)
10.2165/00003495-200363200-00001 / Drugs / Appropriate empirical antibacterial therapy for nosocomial infections: Getting it right the first time by Kollef (2003)
10.1016/j.diagmicrobio.2005.10.004 / Diagn. Microbiol. Infect. Dis. / Making the most of surveillance studies: Summary of the OPTAMA program by Kuti (2005)
10.1128/AAC.48.7.2464-2470.2004 / Antimicrob. Agents Chemother. / Optimizing Pharmacodynamic Target Attainment using the MYSTIC Antibiogram: Data collected in North America in 2002 by Kuti (2004)
10.1001/archinte.162.13.1515 / Arch. Intern. Med. / Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The preantibiotic era has returned by Landman (2002)
10.1093/jac/45.4.433 / J. Antimicrob. Chemother. / Interplay between the MexA–MexB–OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa by Li (2000)
10.1093/jac/47.3.247 / J. Antimicrob. Chemother. / Of Pseudomonas, porins, pumps and carbapenems by Livermore (2001)
10.1086/338782 / Clin. Infect. Dis. / Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? by Livermore (2002)
10.1093/jac/49.1.218 / J. Antimicrob. Chemother. / Ciprofloxacin resistance—‘early warning’ signs from the MYSTIC Surveillance Programme? by Masterton (2002)
10.1016/S0195-6701(03)00294-9 / J. Hosp. Infect. / Appropriate antimicrobial treatment in nosocomial infections—the clinical challenges by Masterton (2003)
10.1093/jac/dkh511 / J. Antimicrob. Chemother. / The OPTAMA programme: Utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe by Masterton (2005)
10.1016/S0149-2918(04)80001-8 / Clin. Ther. / Optimizing antimicrobial pharmacodynamics: Dosage strategies for meropenem by Mattoes (2004)
10.1016/S0732-8893(01)00321-2 / Diagn. Microbiol. Infect. Dis. / Unit differences in pathogen occurrence arising from the MYSTIC Program European database (1997–2000) by Mendes (2001)
10.1093/jac/dkh039 / J. Antimicrob. Chemother. / Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001) by Mutnick (2004)
{'key': '10.1016/j.diagmicrobio.2005.10.002_bib35', 'series-title': 'Methods for dilution antimicrobial test for bacteria that grow aerobically', 'author': 'National Committee for Clinical Laboratory Standards', 'year': '2003'} / Methods for dilution antimicrobial test for bacteria that grow aerobically by National Committee for Clinical Laboratory Standards (2003)
10.1001/jama.289.7.885 / JAMA / Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use by Neuhauser (2003)
10.1097/01.CCM.0000050464.70382.D6 / Crit. Care Med. / Appropriate use of antimicrobial agents: Challenges and strategies for improvement by Niederman (2003)
10.1093/jac/46.suppl_2.25 / J Antimicrob Chemother / MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: Resistance implications in the treatment of serious infections by Pfaller (2000)
10.1016/S0732-8893(01)00319-4 / Diagn. Microbiol. Infect. Dis. / Antimicrobial resistance trends in medical centers using carbapenems: Report of 1999 and 2000 results from the MYSTIC Program (USA) by Pfaller (2001)
10.1016/j.diagmicrobio.2004.02.003 / Diagn. Microbiol. Infect. Dis. / Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003) by Rhomberg (2004)
{'key': '10.1016/j.diagmicrobio.2005.10.002_bib41', 'first-page': '21', 'article-title': 'Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)', 'volume': '63', 'author': 'Rodriguez', 'year': '2003', 'journal-title': 'Medicina (B Aires)'} / Medicina (B Aires) / Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001) by Rodriguez (2003)
10.1016/j.ijantimicag.2004.08.013 / Int. J. Antimicrob. Agents / Dissemination and diversity of metallo-β-lactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program by Sader (2005)
10.1128/AAC.48.1.329-332.2004 / Antimicrob. Agents Chemother. / blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States by Toleman (2004)
{'key': '10.1016/j.diagmicrobio.2005.10.002_bib44', 'first-page': '285', 'article-title': 'Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates', 'volume': '61', 'author': 'Tuchilus', 'year': '2002', 'journal-title': 'Roum. Arch. Microbiol. Immunol.'} / Roum. Arch. Microbiol. Immunol. / Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates by Tuchilus (2002)
10.1093/jac/46.suppl_2.9 / J. Antimicrob. Chemother. / MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): A global overview by Turner (2000)
10.1016/j.diagmicrobio.2004.11.013 / Diagn. Microbiol. Infect. Dis. / Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalised in European medical centres: 6-year report of the MYSTIC surveillance study (1997–2002) by Turner (2005)
10.1016/S0924-8579(99)00115-6 / Int. J. Antimicrob. Agents / The MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) programme by Turner (1999)
10.1016/j.ijantimicag.2003.07.003 / Int. J. Antimicrob. Agents / Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme by Unal (2004)
{'key': '10.1016/j.diagmicrobio.2005.10.002_bib49', 'first-page': '595', 'article-title': 'An update on antibiotic-resistant gram-negative bacteria', 'volume': '21', 'author': 'Villegas', 'year': '2004', 'journal-title': 'Infect. Med.'} / Infect. Med. / An update on antibiotic-resistant gram-negative bacteria by Villegas (2004)

Dates

Type	When
Created	19 years, 8 months ago (Dec. 19, 2005, 1:43 p.m.)
Deposited	6 years, 7 months ago (Jan. 19, 2019, 8:24 a.m.)
Indexed	1 month ago (July 28, 2025, 5:32 p.m.)
Issued	19 years, 8 months ago (Dec. 1, 2005)
Published	19 years, 8 months ago (Dec. 1, 2005)
Published Print	19 years, 8 months ago (Dec. 1, 2005)

Funders 0

None

BibTeX

@article{Unal_2005, title={Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004}, volume={53}, ISSN={0732-8893}, url={http://dx.doi.org/10.1016/j.diagmicrobio.2005.10.002}, DOI={10.1016/j.diagmicrobio.2005.10.002}, number={4}, journal={Diagnostic Microbiology and Infectious Disease}, publisher={Elsevier BV}, author={Unal, Serhat and Garcia-Rodriguez, Jose Angel}, year={2005}, month=dec, pages={265–271} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        28
      ]
    ],
    "date-time": "2025-07-28T21:32:23Z",
    "timestamp": 1753738343268
  },
  "reference-count": 49,
  "publisher": "Elsevier BV",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2005,
            12,
            1
          ]
        ],
        "date-time": "2005-12-01T00:00:00Z",
        "timestamp": 1133395200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        12
      ]
    ]
  },
  "DOI": "10.1016/j.diagmicrobio.2005.10.002",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        12,
        19
      ]
    ],
    "date-time": "2005-12-19T18:43:01Z",
    "timestamp": 1135017781000
  },
  "page": "265-271",
  "source": "Crossref",
  "is-referenced-by-count": 55,
  "title": "Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002\u20132004",
  "prefix": "10.1016",
  "volume": "53",
  "author": [
    {
      "given": "Serhat",
      "family": "Unal",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Jose Angel",
      "family": "Garcia-Rodriguez",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "695",
      "DOI": "10.1093/jac/45.5.695",
      "article-title": "Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in Turkey",
      "volume": "45",
      "author": "Aksaray",
      "year": "2000",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "DOI": "10.2165/00003495-199958010-00005",
      "article-title": "Current guidelines for the treatment and prevention of nosocomial infections",
      "volume": "58",
      "author": "Bergogne-Berezin",
      "year": "1999",
      "journal-title": "Drugs"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "440",
      "DOI": "10.1007/BF03160479",
      "article-title": "The increasing role of Acinetobacter species as nosocomial pathogens",
      "volume": "3",
      "author": "Bergogne-Berezin",
      "year": "2001",
      "journal-title": "Curr. Infect. Dis. Rep."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "196",
      "DOI": "10.1007/s10096-005-1294-x",
      "article-title": "Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: Molecular epidemiology and in vitro activity of polymyxin B",
      "volume": "24",
      "author": "Bratu",
      "year": "2005",
      "journal-title": "Eur. J. Clin. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "DOI": "10.1097/01.qco.0000136927.29802.68",
      "article-title": "Epidemiology and control of antibiotic resistance in the intensive care unit",
      "volume": "17",
      "author": "Carlet",
      "year": "2004",
      "journal-title": "Curr. Opin. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "DOI": "10.1016/j.ijantimicag.2004.03.016",
      "article-title": "Antibiotic policies in Central Eastern Europe",
      "volume": "24",
      "author": "Cizman",
      "year": "2004",
      "journal-title": "Int. J. Antimicrob. Agents"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib7",
      "series-title": "Performance standards for antimicrobial susceptibility testing",
      "author": "Clinical and Laboratory Standards Institute",
      "year": "2005"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "DOI": "10.1046/j.1469-0691.2000.00062.x",
      "article-title": "Meropenem: Clinical response in relation to in vitro susceptibility",
      "volume": "6",
      "author": "Drusano",
      "year": "2000",
      "journal-title": "Clin. Microbiol. Infect."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "317",
      "DOI": "10.1046/j.1469-0691.2002.00436.x",
      "article-title": "Antibiotic resistance\u2014from pathogen to disease surveillance",
      "volume": "8",
      "author": "Finch",
      "year": "2002",
      "journal-title": "Clin. Microbiol. Infect."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "370",
      "DOI": "10.1007/s100960050497",
      "article-title": "Antimicrobial resistance in European isolates of Pseudomonas aeruginosa",
      "volume": "19",
      "author": "Fluit",
      "year": "2000",
      "journal-title": "Eur. J. Clin. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "104",
      "DOI": "10.1086/320183",
      "article-title": "Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997\u20131999)",
      "volume": "32",
      "author": "Gales",
      "year": "2001",
      "journal-title": "Clin. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "DOI": "10.1179/joc.2002.14.1.25",
      "article-title": "Antimicrobial resistance in gram-negative isolates from European intensive care units: Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme",
      "volume": "14",
      "author": "Garcia-Rodriguez",
      "year": "2002",
      "journal-title": "J. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "DOI": "10.1016/S0732-8893(01)00320-0",
      "article-title": "MYSTIC Program: Summary of European data from 1997 to 2000",
      "volume": "41",
      "author": "Goossens",
      "year": "2001",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "67",
      "DOI": "10.1001/jama.281.1.67",
      "article-title": "Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups",
      "volume": "281",
      "author": "Hanberger",
      "year": "1999",
      "journal-title": "JAMA"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "DOI": "10.1093/jac/47.6.789",
      "article-title": "Antimicrobial susceptibility of Pseudomonas aeruginosa: Results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test",
      "volume": "47",
      "author": "Henwood",
      "year": "2001",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "397S",
      "DOI": "10.1378/chest.119.2_suppl.397S",
      "article-title": "Resistance patterns among nosocomial pathogens: Trends over the past few years",
      "volume": "119",
      "author": "Jones",
      "year": "2001",
      "journal-title": "Chest"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1016/j.diagmicrobio.2004.03.016",
      "article-title": "Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999\u20132003)",
      "volume": "49",
      "author": "Jones",
      "year": "2004",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "239",
      "DOI": "10.1016/S0732-8893(02)00390-5",
      "article-title": "Geographic variations in activity of broad-spectrum \u03b2-lactams against Pseudomonas aeruginosa: Summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997\u20132000)",
      "volume": "43",
      "author": "Jones",
      "year": "2002",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "DOI": "10.1016/S0732-8893(01)00318-2",
      "article-title": "Determining the value of antimicrobial surveillance programs",
      "volume": "41",
      "author": "Jones",
      "year": "2001",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "379",
      "DOI": "10.1016/S0732-8893(98)00037-6",
      "article-title": "Bacterial resistance: A worldwide problem",
      "volume": "31",
      "author": "Jones",
      "year": "1998",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "109",
      "DOI": "10.1016/j.diagmicrobio.2004.03.003",
      "article-title": "Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa from the MYSTIC surveillance program: The OPTAMA Program, South America 2002",
      "volume": "49",
      "author": "Kiffer",
      "year": "2004",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "2157",
      "DOI": "10.2165/00003495-200363200-00001",
      "article-title": "Appropriate empirical antibacterial therapy for nosocomial infections: Getting it right the first time",
      "volume": "63",
      "author": "Kollef",
      "year": "2003",
      "journal-title": "Drugs"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib23",
      "doi-asserted-by": "crossref",
      "DOI": "10.1016/j.diagmicrobio.2005.10.004",
      "article-title": "Making the most of surveillance studies: Summary of the OPTAMA program",
      "author": "Kuti",
      "year": "2005",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "2464",
      "DOI": "10.1128/AAC.48.7.2464-2470.2004",
      "article-title": "Optimizing Pharmacodynamic Target Attainment using the MYSTIC Antibiogram: Data collected in North America in 2002",
      "volume": "48",
      "author": "Kuti",
      "year": "2004",
      "journal-title": "Antimicrob. Agents Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "1515",
      "DOI": "10.1001/archinte.162.13.1515",
      "article-title": "Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The preantibiotic era has returned",
      "volume": "162",
      "author": "Landman",
      "year": "2002",
      "journal-title": "Arch. Intern. Med."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "433",
      "DOI": "10.1093/jac/45.4.433",
      "article-title": "Interplay between the MexA\u2013MexB\u2013OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa",
      "volume": "45",
      "author": "Li",
      "year": "2000",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "247",
      "DOI": "10.1093/jac/47.3.247",
      "article-title": "Of Pseudomonas, porins, pumps and carbapenems",
      "volume": "47",
      "author": "Livermore",
      "year": "2001",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "634",
      "DOI": "10.1086/338782",
      "article-title": "Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?",
      "volume": "34",
      "author": "Livermore",
      "year": "2002",
      "journal-title": "Clin. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "218",
      "DOI": "10.1093/jac/49.1.218",
      "article-title": "Ciprofloxacin resistance\u2014\u2018early warning\u2019 signs from the MYSTIC Surveillance Programme?",
      "author": "Masterton",
      "year": "2002",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "issue": "Suppl 1",
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S0195-6701(03)00294-9",
      "article-title": "Appropriate antimicrobial treatment in nosocomial infections\u2014the clinical challenges",
      "volume": "55",
      "author": "Masterton",
      "year": "2003",
      "journal-title": "J. Hosp. Infect."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "DOI": "10.1093/jac/dkh511",
      "article-title": "The OPTAMA programme: Utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe",
      "volume": "55",
      "author": "Masterton",
      "year": "2005",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "1187",
      "DOI": "10.1016/S0149-2918(04)80001-8",
      "article-title": "Optimizing antimicrobial pharmacodynamics: Dosage strategies for meropenem",
      "volume": "26",
      "author": "Mattoes",
      "year": "2004",
      "journal-title": "Clin. Ther."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "DOI": "10.1016/S0732-8893(01)00321-2",
      "article-title": "Unit differences in pathogen occurrence arising from the MYSTIC Program European database (1997\u20132000)",
      "volume": "41",
      "author": "Mendes",
      "year": "2001",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "290",
      "DOI": "10.1093/jac/dkh039",
      "article-title": "Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999\u20132001)",
      "volume": "53",
      "author": "Mutnick",
      "year": "2004",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib35",
      "series-title": "Methods for dilution antimicrobial test for bacteria that grow aerobically",
      "author": "National Committee for Clinical Laboratory Standards",
      "year": "2003"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "885",
      "DOI": "10.1001/jama.289.7.885",
      "article-title": "Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use",
      "volume": "289",
      "author": "Neuhauser",
      "year": "2003",
      "journal-title": "JAMA"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "608",
      "DOI": "10.1097/01.CCM.0000050464.70382.D6",
      "article-title": "Appropriate use of antimicrobial agents: Challenges and strategies for improvement",
      "volume": "31",
      "author": "Niederman",
      "year": "2003",
      "journal-title": "Crit. Care Med."
    },
    {
      "issue": "Suppl T2",
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "DOI": "10.1093/jac/46.suppl_2.25",
      "article-title": "MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: Resistance implications in the treatment of serious infections",
      "volume": "46",
      "author": "Pfaller",
      "year": "2000",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1016/S0732-8893(01)00319-4",
      "article-title": "Antimicrobial resistance trends in medical centers using carbapenems: Report of 1999 and 2000 results from the MYSTIC Program (USA)",
      "volume": "41",
      "author": "Pfaller",
      "year": "2001",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "273",
      "DOI": "10.1016/j.diagmicrobio.2004.02.003",
      "article-title": "Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003)",
      "volume": "49",
      "author": "Rhomberg",
      "year": "2004",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib41",
      "first-page": "21",
      "article-title": "Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)",
      "volume": "63",
      "author": "Rodriguez",
      "year": "2003",
      "journal-title": "Medicina (B Aires)"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "DOI": "10.1016/j.ijantimicag.2004.08.013",
      "article-title": "Dissemination and diversity of metallo-\u03b2-lactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program",
      "volume": "25",
      "author": "Sader",
      "year": "2005",
      "journal-title": "Int. J. Antimicrob. Agents"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "329",
      "DOI": "10.1128/AAC.48.1.329-332.2004",
      "article-title": "blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States",
      "volume": "48",
      "author": "Toleman",
      "year": "2004",
      "journal-title": "Antimicrob. Agents Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib44",
      "first-page": "285",
      "article-title": "Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates",
      "volume": "61",
      "author": "Tuchilus",
      "year": "2002",
      "journal-title": "Roum. Arch. Microbiol. Immunol."
    },
    {
      "issue": "Suppl T2",
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "DOI": "10.1093/jac/46.suppl_2.9",
      "article-title": "MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): A global overview",
      "volume": "46",
      "author": "Turner",
      "year": "2000",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "281",
      "DOI": "10.1016/j.diagmicrobio.2004.11.013",
      "article-title": "Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalised in European medical centres: 6-year report of the MYSTIC surveillance study (1997\u20132002)",
      "volume": "51",
      "author": "Turner",
      "year": "2005",
      "journal-title": "Diagn. Microbiol. Infect. Dis."
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "DOI": "10.1016/S0924-8579(99)00115-6",
      "article-title": "The MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) programme",
      "volume": "13",
      "author": "Turner",
      "year": "1999",
      "journal-title": "Int. J. Antimicrob. Agents"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib48",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "DOI": "10.1016/j.ijantimicag.2003.07.003",
      "article-title": "Bacteraemia in Europe\u2014antimicrobial susceptibility data from the MYSTIC surveillance programme",
      "volume": "23",
      "author": "Unal",
      "year": "2004",
      "journal-title": "Int. J. Antimicrob. Agents"
    },
    {
      "key": "10.1016/j.diagmicrobio.2005.10.002_bib49",
      "first-page": "595",
      "article-title": "An update on antibiotic-resistant gram-negative bacteria",
      "volume": "21",
      "author": "Villegas",
      "year": "2004",
      "journal-title": "Infect. Med."
    }
  ],
  "container-title": "Diagnostic Microbiology and Infectious Disease",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S073288930500252X?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S073288930500252X?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        1,
        19
      ]
    ],
    "date-time": "2019-01-19T13:24:56Z",
    "timestamp": 1547904296000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S073288930500252X"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2005,
        12
      ]
    ]
  },
  "references-count": 49,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2005,
          12
        ]
      ]
    }
  },
  "alternative-id": [
    "S073288930500252X"
  ],
  "URL": "http://dx.doi.org/10.1016/j.diagmicrobio.2005.10.002",
  "relation": {},
  "ISSN": [
    "0732-8893"
  ],
  "subject": [],
  "container-title-short": "Diagnostic Microbiology and Infectious Disease",
  "published": {
    "date-parts": [
      [
        2005,
        12
      ]
    ]
  }
}